NCT05028114
Who may be able to join
Who might be able to join this trial:
- You must be between 18 and 65 years old at the time of signing the consent form.
- You must be considered generally healthy, based on a doctor's review of your medical history, physical exam, blood tests, and heart monitoring.
- You must weigh at least 45 kg (about 99 lbs) and have a BMI between 18.0 and 32.0.
- Both men and women are welcome to apply.
- You must be willing to follow study procedures, including having blood drawn, staying at the clinic for required periods, and following specific meal requirements.
- You must be a non-smoker or smoke no more than 10 cigarettes per week, and have done so for at least 3 months before your screening appointment.
Who may not be able to join:
- You may not be eligible if you have a history of, or currently have, stomach or digestive problems that could be risky when taking the study treatment or could affect the study results (confirm with trial site).
- You may not be eligible if you have taken any over-the-counter or prescription medicines, including herbal supplements, within 7 days before receiving the study treatment — though paracetamol/acetaminophen (up to 2g per day), hormone replacement therapy, and hormonal contraception are allowed.
- You may not be eligible if you are currently following a ketogenic diet, a low-fat diet, or regularly using products such as medium chain triglycerides, ketone esters, or similar ketogenic supplements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Area under the concentration-time curve (AUC) of total ketones (β-hydroxybutyrate and acetoacetate) after single-dose administration of tricaprilin and placebo formulations (Part 1, Part 2); Maximum observed concentration (Cmax) of total ketones (β-hydroxybutyrate and acetoacetate) after single-dose administration of tricaprilin and placebo formulations (Part 1, Part 2); Time of maximum concentration (Tmax) of total ketones (β-hydroxybutyrate and acetoacetate) after single-dose administration of tricaprilin and placebo formulations (Part 1, Part 2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.